金城医药 (300233.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(金城医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 3,538,312,459.652,568,752,667.571,705,293,296.69829,526,542.003,505,716,962.182,591,255,169.471,851,785,050.63953,062,199.12
 营业利润(元) 225,849,216.89175,516,338.76134,174,184.2068,747,551.80353,777,276.11338,944,390.07284,002,153.02145,165,251.95
 利润总额(元) 225,407,539.95176,301,377.39135,692,352.5570,236,722.17345,965,986.40328,347,798.15272,866,130.23144,236,962.95
 净利润(元) 193,310,999.11146,655,023.18110,772,560.8554,879,668.97285,874,231.66267,089,226.39224,207,085.73116,066,574.08
 归属于母公司股东的净利润(元) 174,709,358.21132,480,355.98101,709,417.1350,154,655.33273,364,594.00258,394,428.98218,970,919.44112,478,901.17
盈利能力:
 销售毛利率(%) 43.7342.3443.1342.6946.2246.8444.5443.19
 销售净利率(%) 5.465.716.506.628.1510.3112.1112.18
 净资产收益率(%) 4.773.642.811.40----
 总资产报酬率ROA(%) 4.013.192.481.38----
 投入资本回报率ROIC(%) 3.912.952.291.126.466.075.172.70
营运能力:
 存货周转率(次) 3.692.901.860.99----
 应收账款周转率(次) 5.955.202.871.33----
 总资产周转率(次) 0.600.440.300.15----
偿债能力:
 资产负债率(%) 36.0937.0536.0736.6837.1935.6036.0334.73
 股东权益比率(%) 62.7861.9062.9462.3661.9263.5663.1864.39
 已获利息倍数(倍) 22.9319.9722.099.8224.5362.8290.6235.16
 流动比率 1.481.501.421.441.361.371.441.56
 速动比率 1.141.181.051.050.990.991.101.25
发展能力:
 营业收入增长率(%) 0.93-0.87-7.91-12.9611.7023.6642.9856.50
 营业利润增长率(%) -36.16-48.22-52.76-52.6468.4395.62116.37112.50
 税后利润增长率(%) -36.09-48.73-53.55-55.41153.15114.72135.44121.18
 净资产增长率(%) 2.962.023.424.676.275.815.230.49
 总资产增长率(%) 1.544.763.828.0710.4410.2311.247.73

前瞻产业研究院